ICAM1 and cancer: Cheng and Liang (2015) who conducted a meta-analysis (involving 18 case-control studies with 4,844 cancer cases and 5,618 healthy controls) suggested that ICAM-1 G241R polymorphism might be a genetic risk factor for development of cancer in general, especially in European population whereas K469E polymorphism might not act as a cancer risk factor.